Oryzon Genomics S.A. (0RDB.L) LSE

2.99

-0.08(-2.61%)

Updated at September 29 04:03PM

Currency In EUR

Valuation

Market Cap130.35M
Enterprise Value136.99M
P/E Ratio-46.59
PEG Ratio151.41
Price/Sales Ratio31.7
Price/Book Ratio1.71
Enterprise/Revenue29.34
Enterprise/EBITDA864.48

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-0.57
Operating Margin-0.01

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.04

Income Statement

Revenue15.67M
Revenue/Share0.11
Gross Profit15.4M
EBITDA-4.89M
Net Income-3.7M
Diluted EPS-0.06

Balance Sheet

Total Cash10.79M
Total Cash/Share0.48
Total Debt19.34M
Total Debt/Equity0.12
Current Ratio2.62
Book Value Per Share1.76

Price History

52-Week Change63.39
52-Week High3.18
52-Week Low1.6
Moving Average 50 Days1.93
Moving Average 200 Days2.06

Statistics

Average Volume2,518
Shares Outstanding77.59M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A